Characterization of 11C-GSK1482160 for Targeting the P2X7 Receptor as a Biomarker for Neuroinflammation

dc.contributor.authorTerrito, Paul R.
dc.contributor.authorMeyer, Jill A.
dc.contributor.authorPeters, Jonathan S.
dc.contributor.authorRiley, Amanda A.
dc.contributor.authorMcCarthy, Brian P.
dc.contributor.authorGao, Mingzhang
dc.contributor.authorWang, Min
dc.contributor.authorGreen, Mark A.
dc.contributor.authorZheng, Qi-Huang
dc.contributor.authorHutchins, Gary D.
dc.contributor.departmentRadiology and Imaging Sciences, School of Medicineen_US
dc.date.accessioned2017-11-17T16:17:03Z
dc.date.available2017-11-17T16:17:03Z
dc.date.issued2017-03
dc.description.abstractThe purinergic receptor subtype 7 (P2X7R) represents a novel molecular target for imaging neuroinflammation via PET. GSK1482160, a potent P2X7R antagonist, has high receptor affinity, high blood–brain barrier penetration, and the ability to be radiolabeled with 11C. We report the initial physical and biologic characterization of this novel ligand. Methods: 11C-GSK1482160 was synthesized according to published methods. Cell density studies were performed on human embryonic kidney cell lines expressing human P2X7R (HEK293-hP2X7R) and underwent Western blotting, an immunofluorescence assay, and radioimmunohistochemistry analysis using P2X7R polyclonal antibodies. Receptor density and binding potential were determined by saturation and association–disassociation kinetics, respectively. Peak immune response to lipopolysaccharide treatment in mice was determined in time course studies and analyzed via Iba1 and P2X7R Western blotting and Iba1 immunohistochemistry. Whole-animal biodistribution studies were performed on saline- or lipopolysaccharide-treated mice at 15, 30, and 60 min after radiotracer administration. Dynamic in vivo PET/CT was performed on the mice at 72 h after administration of saline, lipopolysaccharide, or lipopolysaccharide + blocking, and 2-compartment, 5-parameter tracer kinetic modeling of brain regions was performed. Results: P2X7R changed linearly with concentrations or cell numbers. For high-specific-activity 11C-GSK1482160, receptor density and Kd were 1.15 ± 0.12 nM and 3.03 ± 0.10 pmol/mg, respectively, in HEK293-hP2X7R membranes. Association constant kon, dissociation constant koff, and binding potential (kon/koff) in HEK293-hP2X7R cells were 0.2312 ± 0.01542 min−1⋅nM−1, 0.2547 ± 0.0155 min−1, and 1.0277 ± 0.207, respectively. Whole-brain Iba1 expression in lipopolysaccharide-treated mice peaked by 72 h on immunohistochemistry, and Western blot analysis of P2X7R for saline- and lipopolysaccharide-treated brain sections showed a respective 1.8- and 1.7-fold increase in signal enhancement at 72 h. Biodistribution of 11C-GSK1482160 in saline- and lipopolysaccharide-treated mice at 72 h was statistically significant across all tissues studied. In vivo dynamic 11C-GSK1482160 PET/CT of mice at 72 h after administration of saline, lipopolysaccharide, or lipopolysaccharide + blocking showed a 3.2-fold increase and 97% blocking by 30 min. The total distribution volumes for multiple cortical regions and the hippocampus showed statistically significant increases and were blocked by an excess of authentic standard GSK1482160. Conclusion: The current study provides compelling data that support the suitability of 11C-GSK1482160 as a radioligand targeting P2X7R, a biomarker of neuroinflammation.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationTerrito, P. R., Meyer, J. A., Peters, J. S., Riley, A. A., McCarthy, B. P., Gao, M., … Hutchins, G. D. (2017). Characterization of 11C-GSK1482160 for Targeting the P2X7 Receptor as a Biomarker for Neuroinflammation. Journal of Nuclear Medicine, 58(3), 458–465. https://doi.org/10.2967/jnumed.116.181354en_US
dc.identifier.urihttps://hdl.handle.net/1805/14597
dc.language.isoenen_US
dc.publisherSNMMIen_US
dc.relation.isversionof10.2967/jnumed.116.181354en_US
dc.relation.journalJournal of Nuclear Medicineen_US
dc.rightsPublisher Policyen_US
dc.sourcePublisheren_US
dc.subjectpurinergicen_US
dc.subjectreceptorsen_US
dc.subjectP2X7 receptoren_US
dc.titleCharacterization of 11C-GSK1482160 for Targeting the P2X7 Receptor as a Biomarker for Neuroinflammationen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Territo_2017_characterizaation.pdf
Size:
1.04 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: